Antibiotic Symptoms Reignite Drug Reaction Concerns

Patient monitor displaying vital signs in a hospital room — Photo: Chaikom / Shutterstock

A Georgia woman’s catastrophic 2014 drug reaction left her in a weeks-long coma, and a 2025 antibiotic course reportedly triggered alarming symptoms again.

Story Snapshot

Doctors diagnosed Stevens-Johnson syndrome in 2014 after she started lamotrigine, leading to a medically induced coma.
A Georgia court record cites expert testimony tying the 2014 reaction to improper lamotrigine titration.
In 2025, she reported facial swelling and mouth and eye irritation after taking amoxicillin for a tooth infection.
Published research shows antiepileptic drugs account for a notable share of severe skin reactions.

What Happened In 2014: A Rare Drug Reaction With Lasting Harm

In 2014, Khaliah Shaw developed widespread blisters and skin peeling within weeks of starting the mood-stabilizing drug lamotrigine. Doctors diagnosed Stevens-Johnson syndrome, a rare but severe reaction that can be life-threatening. She spent more than a month in a medically induced coma and has lasting injuries and scarring, according to contemporaneous reporting. Local outlets also tied the reaction to lamotrigine, repeating the diagnosis of Stevens-Johnson syndrome after the medication exposure.

A Georgia Court of Appeals record later summarized expert medical testimony on the 2014 event. The expert said, to a reasonable degree of medical probability, that incorrect lamotrigine dosing caused the Stevens-Johnson syndrome and life-threatening rash and that the injury was avoidable. That legal summary underscores the severity of the first episode and links it to how the drug was prescribed. Reports from the period also described a prolonged hospitalization and a difficult recovery.

What She Says Happened In 2025: Symptoms After A Common Antibiotic

In July 2025, Shaw visited a dentist for an infected tooth. She reported warning the dentist about her past drug reaction. The dentist labeled the prior event as an allergy and prescribed the antibiotic amoxicillin, according to her account. After six doses over two days, she reported facial swelling and irritation of her mouth and eyes. The available report describes her symptoms but does not provide a disclosed hospital diagnosis for that episode.

The 2025 account identifies a clear sequence: dental visit, antibiotic prescription, short exposure, and onset of swelling and mucosal irritation. That timing raises concern for another serious reaction, especially given her medical history. However, the public report does not include a physician-confirmed diagnosis, biopsy, or discharge summary for that second event. The 2014 case remains the documented and adjudicated anchor of her medical story.

Why This Matters: Patient Safety Gaps And A Known Medical Risk

Stevens-Johnson syndrome and toxic epidermal necrolysis are rare but known severe skin reactions, most often tied to medications. A meta-analysis found that antiepileptic drugs account for about 23 percent of such cases, placing drugs like lamotrigine among recognized triggers. Clinical literature also associates faster dose increases with higher risk. The 2014 case highlights how a dosing error can move a patient from routine care to the burn unit in a matter of days.

Shaw’s story also points to a common system failure that frustrates people across the political spectrum. Patients often repeat their history to new providers, yet critical details can get reduced to a simple “allergy” label. When records do not follow the patient, or when busy clinics rush, safety flags can be missed. Many readers see this as another sign that large systems protect institutions first and leave patients to catch errors themselves—an exhausting and risky burden.

What Patients And Providers Can Do Right Now

Patients who have had severe drug reactions can carry a printed summary that names the drug, dose history, and the confirmed diagnosis. They can ask each prescriber to review it before writing a new script. Dentists, primary care doctors, and specialists can slow down for high-risk cases, verify past records, and consider alternatives when history raises red flags. Quick checks like electronic allergy alerts help, but clear documentation and informed caution save lives.

The Bigger Picture: Trust, Accountability, And Everyday Care

Stories like this fuel a wider concern: big systems often fail at the basics. People on the right and left both worry about a healthcare maze that is expensive, rushed, and hard to navigate. Shaw’s 2014 injury shows how one mistake can cause lifelong harm. Her 2025 report shows how fear and confusion can return with a common drug. Better records, careful prescribing, and clear patient voices are not political—they are survival tools.